---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-027742"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2023-02-08T23:59:59+00:00"
generated_at: "2026-06-19T21:26:36.631067+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# RxSight prices public offering of 4M shares at $12.50 each for ~$50M gross proceeds

## Summary
- Offering of 4,000,000 shares of common stock at $12.50 per share; gross proceeds ~$50.0M, net ~$46.7M.
- Underwriters granted 30-day option to purchase up to 600,000 additional shares at same price.
- Offering expected to close February 10, 2023; BofA Securities sole bookrunning manager.
- Net proceeds to fund commercial expansion, product development, R&D, and working capital.
- Officers and directors subject to 90-day lock-up restrictions on share sales.

## SEC filing metadata
- accession: 0001193125-23-027742
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2023-02-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000119312523027742/0001193125-23-027742-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000119312523027742/d426433d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-027742
- JSON: https://secwatch.observer/filing/0001193125-23-027742.json
- Plain text: https://secwatch.observer/filing/0001193125-23-027742.txt

## Key facts
- Material Agreements
  RxSight, Inc. entered into Underwriting Agreement with BofA Securities, Inc., as representative of the several underwriters valued at approximately $46.7 million (effective 2023-02-07).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: BofA Securities, Inc., as representative of the several underwriters
  - Value: approximately $46.7 million
  - Effective: 2023-02-07
  source text: On February 7, 2023, RxSight, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc., as representative (the “Representative”) of the several underwriters listed in Schedule 1 thereto (the “Underwriters”), pursuant to which the Company agreed to issue and sell 4,000,000 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common Stock”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1111485/000119312523027742/0001193125-23-027742-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.